Wankhede, a 2008-batch Indian Revenue Service officer, was on deputation to the NCB since September 2020 and is currently Mumbai zonal director of the anti-drugs agency
Sameer Wankhede. File Pic
The tenure of IRS officer Sameer Wankhede with the Narcotics Control Bureau (NCB), which was marked by controversy, would end on December 31, official sources said on Friday.
ADVERTISEMENT
Wankhede, a 2008-batch Indian Revenue Service officer, was on deputation to the NCB since September 2020 and is currently Mumbai zonal director of the anti-drugs agency.
He was earlier posted with the Directorate of Revenue Intelligence (DRI).
As zonal director of NCB, Wankhede was involved in action against the drug syndicates allegedly involving Bollywood celebrities in the aftermath of actor Sushant Singh Rajput's death by suicide.
In October this year, a team led by Wankhede allegedly recovered drugs during a raid on a cruise ship off the Mumbai coast, and arrested actor Shah Rukh Khan's son Aryan along with others.
Also Read: Twitter says Sameer Wankhede's suit in Mumbai court 'frivolous', seeks its dismissal
But subsequently questions were raised about the credentials of independent witnesses used by the NCB during the raid, and it was also alleged that there was an attempt to extort money from Shah Rukh Khan by NCB officials.
Maharashtra minister Nawab Malik targeted Wankhede, alleging that he was born a Muslim but got his job in the Scheduled Castes quota by obtaining a bogus caste certificate.
Wankhede denied the allegation and his father filed a defamation suit against Malik, an NCP leader.
It is not yet clear where he would be posted after his NCB deputation ends, sources said.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
